Physician profile
James E Roth
NPI 1437105608
$1,088.92
in general payments reported to CMS, 2019-2025
9 companies · $17.75 in 2025
The $17.75 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $261 · 2021: $155 · 2022: $85.39 · 2023: $82.30 · 2024: $106 · 2025: $17.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $681.16 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $161.51 | 2019-2025 | Xtampza, Belbuca |
| Stryker Corporation | $85.39 | 2022 | |
| Averitas Pharma INC. | $65.96 | 2024 | Qutenza |
| Gilead Sciences, INC. | $22.65 | 2020 | |
| Axsome Therapeutics, INC. | $22.61 | 2023 | Sunosi |
| Indivior INC. | $20.67 | 2020 | |
| Aerin Medical INC. | $14.89 | 2019 | |
| Harmony Biosciences LLC | $14.08 | 2023 | Wakix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.